BPC-157 and TB-500 are not FDA-approved medications
A 2023 paper in Pharmaceuticals (PMID: 37242459) documented anxiolytic, anticonvulsive, and antidepressant-like effects in animal behavioral assays and reported that BPC-157 attenuated benzodiazepine tolerance development and counteracted serotonin syndrome in rats
These are peptide costs only and do not include clinic consultation fees, which range from $200-500 for initial evaluation
Some take 250-500 mcg once or twice daily
It has at times been granted a food-ingredient designation, which is not the same as approval to treat a medical condition
GHK-Cu peptide has been researched for its potential across a variety of functions (1) including that it may tighten and reverse the thinning of aging skin structure, supporting the extracellular matrix, that it may restore the skin barrier and moderate texture, hyperpigmentation and lesions, may support tissue repair and mitigate inflammation, may stimulate increasing hair follicle size, may exert antioxidant properties and, finally, may exhibit gene restructuring potential